Mayo ClinicHematologic Malignancies: New Therapies and the Evolving Role of Transplant

Chicago, IL
Friday, March 17, 2017 at 7:00am CT - Saturday, March 18, 2017 at 3:00pm CT

Icon 16x16 folder heart Save   Icon 16x16 email to friend Email to a friend

Icon 16x16 map edit


The Westin Chicago River North
320 North Dearborn Street
Chicago, IL 60654

Icon 16x16 clock

Start time

Friday, March 17, 2017 at 7:00am CT
Icon 16x16 date add

Interested in attending this event?

Icon 16x16 information



Acute Myeloid Leukemia, Stem Cell Mobilization, Autologous Graft vs. Tumor Effect, CLL, Risks and Management Options for Relapse of AML Post HCT, Kidney Transplant Tolerance Protocols, Evolving Role of Biomarkers in the Management of Acute GVHD


James M. Foran, M.D., Ivana N. Micallef, M.D., Shaji Kumar, M.D., Luis F. Porrata, M.D., Nasser H. Hanna, M.D., Sameer A. Parikh, M.B.B.S., Alex Adjei, M.D., Ph.D., Daniel J. Weisdorf, M.D., Patrick B. Johnston, M.D., Ph.D., Gabriel T. Bartoo, Pharm.D., R.Ph., Helen E. Heslop, M.D., Francis K. Buadi, M.D., Nandita Khera, M.D., M.P.H., Mrinal S. Patnaik, M.B.B.S., Mark D. Stegall, M.D., Ruben A. Mesa, M.D., Saad J. Kenderian, M.B., Ch.B., William J. Hogan, M.B., B.Ch., Mark R. Litzow, M.D.

CE Credits This event offers 11.0 CME credits to attendees
CE accredited by Mayo School of Continuous Professional Development